Regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate is effective for reducing nosebleeds in children and adults with von Willebrand disease

被引：0
|
作者：
Boban, A. [1 ,2 ]
Sidonio, R. F., Jr. [3 ]
Dubey, L. [4 ]
Vilchevska, K. [5 ]
Inati, A. [6 ,7 ,8 ,9 ]
Khayat, C. D. [10 ]
机构：
[1] Univ Hosp Ctr Zagreb, Dept Internal Med, Zagreb, Croatia
[2] Zagreb Univ, Sch Med, Zagreb, Croatia
[3] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA
[4] Lviv Reg Council, Communal Nonprofit Enterprise Western Ukrainian S, Lvov, Ukraine
[5] Natl Specialized Childrens Hosp, Kiev, Ukraine
[6] NINI Hosp, Tripoli, Libya
[7] NINI Hosp, Byblos, Libya
[8] LAU Gilbert & Rose Marie Chaghoury Sch Med, Tripoli, Libya
[9] LAU Gilbert & Rose Marie Chaghoury Sch Med, Byblos, Libya
[10] St Joseph Univ, Hotel Dieu de France Hosp, Beirut, Lebanon
来源：
HAEMOPHILIA | 2024年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OR04
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [21] TREATMENT WITH A PLASMA-DERIVED VON WILLEBRAND FACTOR (VWF) ALMOST DEVOID OF FACTOR VIII IN PAEDIATRIC PATIENTS WITH VON WILLEBRAND DISEASE (VWD): A POOLED ANALYSIS
    Goudemand, J.
    Borel-Derlon, A.
    Henriet, C.
    Repesse, Y.
    Susen, S.
    [J]. HAEMOPHILIA, 2023, 29 : 147 - 147
  • [22] TREATMENT WITH A PLASMA-DERIVED VON WILLEBRAND FACTOR (VWF) ALMOST DEVOID OF FACTOR VIII IN ELDERLY PATIENTS WITH VON WILLEBRAND DISEASE (VWD): A POOLED ANALYSIS
    Goudemand, J.
    Derlon, A. Borel
    Henriet, C.
    Susen, S.
    Repesse, Y.
    [J]. HAEMOPHILIA, 2022, 28 : 109 - 110
  • [23] Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease
    Batlle, Javier
    Fernanda Lopez-Fernandez, Maria
    Loures Fraga, Esther
    Rodriguez Trillo, Angela
    Almudena Perez-Rodriguez, Maria
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (02) : 89 - 100
  • [24] Safety of a pasteurized plasma-derived Factor VIII and von Willebrand factor concentrate: analysis of 33 years of pharmacovigilance data
    Kouides, Peter
    Wawra-Hehenberger, Kathrin
    Sajan, Anna
    Mead, Henry
    Simon, Toby
    [J]. TRANSFUSION, 2017, 57 (10) : 2390 - 2403
  • [25] Von Willebrand factor/factor VIII concentrate (Humate-P®) for surgical prophylaxis of excessive bleeding in patients with von Willebrand disease (VWD).
    Gill, JC
    DiPaola, J
    Bernstein, J
    Leissinger, CA
    Valentino, L
    Friedman, C
    Knaub, S
    [J]. BLOOD, 2005, 106 (11) : 509A - 509A
  • [26] Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand disease
    Roussi, J
    Turecek, PL
    André, P
    Bonneau, M
    Pignaud, G
    Sollier, CBD
    Schlokat, U
    Dorner, F
    Schwarz, HP
    Drouet, L
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (04) : 361 - 372
  • [27] REAL-WORLD EFFICACY AND SAFETY OF PLASMA-DERIVED VON WILLEBRAND FACTOR-CONTAINING FACTOR VIII CONCENTRATES IN PATIENTS WITH VON WILLEBRAND DISEASE IN ITALY
    Federici, A. B.
    Mairal, E.
    [J]. HAEMOPHILIA, 2023, 29 : 145 - 146
  • [28] ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates
    Peyvandi, Flora
    Mannucci, Pier M.
    Valsecchi, Carla
    Pontiggia, Silvia
    Farina, Claudio
    Retzios, Anastassios D.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (10) : 895 - 898
  • [29] ADAMTS-13 content of plasma-derived factor VIII/von Willebrand factor concentrates
    Kingsland, Sarah
    Feldman, Peter
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : 667 - 668
  • [30] Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates
    Clifton, James G.
    Huang, Feilei
    Kovac, Spomenka
    Yang, Xinli
    Hixson, Douglas C.
    Josic, Djuro
    [J]. ELECTROPHORESIS, 2009, 30 (20) : 3636 - 3646
12345